Cargando…

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis

BACKGROUND: KRAS mutations are common in colorectal cancer (CRC). The role of KRAS mutation status as a prognostic factor remains controversial, and most large population-based cohorts usually consist of patients with non-metastatic CRC. We evaluated the impact of KRAS mutations on the time to recur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hae Su, Heo, Jin Seok, Lee, Jeeyun, Lee, Ji Yun, Lee, Min-Young, Lim, Sung Hee, Lee, Woo Yong, Kim, Seok Hyung, Park, Yoon Ah, Cho, Yong Beom, Yun, Seong Hyeon, Kim, Seung Tae, Park, Joon Oh, Lim, Ho Yeong, Choi, Yong Soo, Kwon, Woo Il, Kim, Hee Cheol, Park, Young Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758097/ https://www.ncbi.nlm.nih.gov/pubmed/26887348 http://dx.doi.org/10.1186/s12885-016-2141-4

Ejemplares similares

Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer
por: Kim, Tae Gyu, et al.
Publicado: (2017)

Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
por: Baek, Kyung Kee, et al.
Publicado: (2010)

Clinical Outcomes of Neoadjuvant Chemotherapy in Colorectal Cancer Patients With Synchronous Resectable Liver Metastasis: A Propensity Score Matching Analysis
por: Park, Sung Hae, et al.
Publicado: (2021)

The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution
por: Kim, Seung Tae, et al.
Publicado: (2016)

Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis
por: Huh, Jung Wook, et al.
Publicado: (2015)

Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation
por: Huh, Jung Wook, et al.
Publicado: (2016)

Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer
por: Yoo, Gyu Sang, et al.
Publicado: (2020)

A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer
por: Jo, Hyunji, et al.
Publicado: (2023)

Proteomic identification of arginine-methylated proteins in colon cancer cells and comparison of messenger RNA expression between colorectal cancer and adjacent normal tissues
por: Lim, Yongchul, et al.
Publicado: (2022)

Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer
por: Lee, Hyebin, et al.
Publicado: (2012)

Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan
por: Kim, Seung Tae, et al.
Publicado: (2015)

Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation
por: Lee, Taehyang, et al.
Publicado: (2018)

Elevated CEA is associated with worse survival in recurrent rectal cancer
por: Cho, Won Kyung, et al.
Publicado: (2017)

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment
por: Song, Haa-Na, et al.
Publicado: (2016)

Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer
por: Oh, Bo Young, et al.
Publicado: (2022)

Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors
por: Park, Charny, et al.
Publicado: (2015)

Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator
por: Oh, Bo Young, et al.
Publicado: (2019)

Transanal Endoscopic and Transabdominal Robotic Total Mesorectal Excision for Mid-to-Low Rectal Cancer: Comparison of Short-term Postoperative and Oncologic Outcomes by Using a Case-Matched Analysis
por: Lee, Ki Young, et al.
Publicado: (2018)

Risk Factors of Anastomotic Leakage and Long-Term Survival After Colorectal Surgery
por: Park, Jong Seob, et al.
Publicado: (2016)

Analgesic efficacy of ropivacaine wound infusion after laparoscopic colorectal surgery
por: Oh, Bo Young, et al.
Publicado: (2016)

Has the COVID-19 Pandemic Caused Upshifting in Colorectal Cancer Stage?
por: Lim, Ji Ha, et al.
Publicado: (2021)

Comparison of Long-Term Survival Outcomes of T4a and T4b Colorectal Cancer
por: Lim, Ji Ha, et al.
Publicado: (2022)

Comparison of Oncologic Outcomes Between Incomplete Obstructive Colon Cancer and Non-Obstructive Colon Cancer by Tumor Location
por: Lim, Ji Ha, et al.
Publicado: (2022)

Clinical Significance of Signet-Ring-Cell Colorectal Cancer as a Prognostic Factor
por: Yun, Sang-Oh, et al.
Publicado: (2017)

hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines
por: Kim, Sang Jin, et al.
Publicado: (2014)

Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial
por: Kim, Seung Tae, et al.
Publicado: (2019)

Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status
por: Lee, Jeeyun, et al.
Publicado: (2014)

Are We Predicting Disease Progress of the Rectal Cancer Patients without Surgery after Neoadjuvant Chemoradiotherapy?
por: Oh, Bo Young, et al.
Publicado: (2018)

Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute
por: Shin, Yooju, et al.
Publicado: (2015)

Prognostic Factors and Treatment of Recurrence after Local Excision of Rectal Cancer
por: Choi, Moon Suk, et al.
Publicado: (2021)

Single-port robot-assisted abdominoperineal resection: a case review of the first four experiences
por: Choi, Moon Suk, et al.
Publicado: (2022)

Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Minimally invasive versus open intersphincteric resection of low rectal cancer regardless of neoadjuvant chemoradiotherapy: long-term oncologic outcomes
por: Shin, Jung kyong, et al.
Publicado: (2021)

Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy
por: Il Yu, Jeong, et al.
Publicado: (2016)

Can CCRT/RT Achieve Favorable Oncologic Outcome in Rectal Cancer Patients With High Risk Feature After Local Excision?
por: Kim, Seijong, et al.
Publicado: (2022)

Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients
por: Kim, Seung Tae, et al.
Publicado: (2015)

A Nomogram for Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy Using Semiquantitative Parameters Derived From Sequential PET/CT in Locally Advanced Rectal Cancer
por: Pyo, Dae Hee, et al.
Publicado: (2021)

Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
por: LIM, SUNG HEE, et al.
Publicado: (2023)

Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer
por: Park, Jong Seob, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1mq0cpighd2tdofqc9buo8dd4t